Clearwater Q4 revenue $126.5M (+27.7% YoY); guides FY2025 rev $535.5-542M; $1.5B Enfusion deal noted

Clearwater Analytics Holdings, Inc.

2024-FY EPS reported $1.68 revenue$451,803,000

Q4 revenue $126.5M (+27.7% YoY); ARR $474.9M (+25.3% YoY); net income $420.3M includes $472M one-time tax benefit from DTA release.
Q4 Adj EBITDA $41.7M (+39% YoY), margin 33.0% (+270 bps); FY2024 Adj EBITDA $145.7M, margin 32.2%.
Net revenue retention rate 116% (vs 107% a year ago); clients 1,462, including 100 with >$1M ARR.
Guidance: Q1 2025 rev ~$125M, Adj EBITDA ~$41.5M; FY2025 rev $535.5-542M (19-20% growth), Adj EBITDA $182-185M (~34% margin).
Recent highlight: announced $1.5B acquisition of Enfusion on Jan 13, 2025, to create front-to-back investment management platform.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.